Michael Castagna, CEO of MannKind Westlake Village-based biotech MannKind continued on its path of revenue growth and cost cutting in the fourth quarter, reporting a 137 percent increase in revenue for all of 2018 on Feb. 26. Fourth quarter revenues rose to $16 million, up more than 250 percent compared to the same period last…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
